CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-11 | Trigilio Jeffrey Chief Financial Officer | Grant or award | +37,500 | 39,750 | ||
| 2022-02-11 | Trigilio Jeffrey Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2022-01-11 | F2 Vision SCS 10% owner | Other disposition | −1,187,734 | 1,724,611 | ||
| 2021-10-18 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +2,710,000 | 2,710,000 | ||
| 2021-10-18 | Michaelson Jennifer See Remarks | Option exercise | +4,000 | $4.30 | $17K | 26,911 |
| 2021-10-18 | Michaelson Jennifer See Remarks | Sale | −3,396 | $21.10 | $72K | 23,515 |
| 2021-10-18 | Michaelson Jennifer See Remarks | Sale | −204 | $22.40 | $5K | 23,311 |
| 2021-10-18 | Michaelson Jennifer See Remarks | Sale | −400 | $23.61 | $9K | 22,911 |
| 2021-10-18 | Michaelson Jennifer See Remarks | Option exercise · Stock Option (Right to Buy) | −4,000 | 217,978 | ||
| 2021-10-15 | Trigilio Jeffrey Chief Financial Officer | Option exercise | +8,000 | $4.30 | $34K | 10,250 |
| 2021-10-15 | Trigilio Jeffrey Chief Financial Officer | Sale | −8,000 | $25.00 | $200K | 2,250 |
| 2021-10-15 | Trigilio Jeffrey Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −8,000 | 229,891 | ||
| 2021-10-15 | Zawel Leigh See Remarks | Sale | −19,574 | $25.00 | $489K | 37,285 |
| 2021-10-07 | Zawel Leigh See Remarks | Sale | −1,079 | $25.00 | $27K | 56,859 |
| 2021-09-20 | Michaelson Jennifer See Remarks | Option exercise | +4,000 | $4.30 | $17K | 26,911 |
| 2021-09-20 | Michaelson Jennifer See Remarks | Sale | −3,200 | $24.34 | $78K | 23,711 |
| 2021-09-20 | Michaelson Jennifer See Remarks | Sale | −800 | $25.20 | $20K | 22,911 |
| 2021-09-20 | Michaelson Jennifer See Remarks | Option exercise · Stock Option (Right to Buy) | −4,000 | 221,978 | ||
| 2021-09-20 | Zawel Leigh See Remarks | Sale | −7,468 | $25.16 | $188K | 57,938 |
| 2021-09-16 | Ebeling Thomas Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 |
Page 15 of 23 · 446 trades